Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Bonsmann G, Luger TA. Beissert S, et al. Among authors: sticherling m. Arch Dermatol. 2007 Dec;143(12):1536-42. doi: 10.1001/archderm.143.12.1536. Arch Dermatol. 2007. PMID: 18087004 Clinical Trial.
Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.
Rzany B, Partscht K, Jung M, Kippes W, Mecking D, Baima B, Prudlo C, Pawelczyk B, Messmer EM, Schuhmann M, Sinkgraven R, Büchner L, Büdinger L, Pfeiffer C, Sticherling M, Hertl M, Kaiser HW, Meurer M, Zillikens D, Messer G. Rzany B, et al. Among authors: sticherling m. Arch Dermatol. 2002 Jul;138(7):903-8. doi: 10.1001/archderm.138.7.903. Arch Dermatol. 2002. PMID: 12071817
[Significant decrease in quality of life in patients with pemphigus vulgaris. Results from the German Bullous Skin Disease (BSD) Study Group].
Mayrshofer F, Hertl M, Sinkgraven R, Sticherling M, Pfeiffer C, Zillikens D, Messer G, Rzany Für Die Deutschebsd-Studiengruppe B. Mayrshofer F, et al. Among authors: sticherling m. J Dtsch Dermatol Ges. 2005 Jun;3(6):431-5. doi: 10.1111/j.1610-0387.2005.05722.x. J Dtsch Dermatol Ges. 2005. PMID: 15892845 German.
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Luger TA. Beissert S, et al. Among authors: sticherling m. Arch Dermatol. 2006 Nov;142(11):1447-54. doi: 10.1001/archderm.142.11.1447. Arch Dermatol. 2006. PMID: 17116835 Clinical Trial.
Clinical manifestations of cutaneous lupus erythematosus.
Kuhn A, Sticherling M, Bonsmann G. Kuhn A, et al. Among authors: sticherling m. J Dtsch Dermatol Ges. 2007 Dec;5(12):1124-37. doi: 10.1111/j.1610-0387.2007.06554.x. J Dtsch Dermatol Ges. 2007. PMID: 18042093 English, German.
Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.
Hertl M, Zillikens D, Borradori L, Bruckner-Tuderman L, Burckhard H, Eming R, Engert A, Goebeler M, Hofmann S, Hunzelmann N, Karlhofer F, Kautz O, Lippert U, Niedermeier A, Nitschke M, Pfütze M, Reiser M, Rose C, Schmidt E, Shimanovich I, Sticherling M, Wolff-Franke S. Hertl M, et al. Among authors: sticherling m. J Dtsch Dermatol Ges. 2008 May;6(5):366-73. doi: 10.1111/j.1610-0387.2007.06602.x. Epub 2008 Jan 14. J Dtsch Dermatol Ges. 2008. PMID: 18201220 English, German.
288 results